U.S. Cancer Statistics Breast Cancer Stat Bite

What to know

Based on the most recent data available, in the United States in 2021, 272,454 new breast cancers were reported in females and in 2022, 42,211 females died from breast cancer.

3 women sitting on a yoga mat

Incidence and death rates

Females had much higher rates of getting breast cancer than dying from breast cancer.

Stage distribution

From 2017 to 2021, about 2 in 3 female breast cancer cases were diagnosed at a localized stage, meaning the cancer had not spread outside the breast. About 1 in 4 female breast cancers were found at a regional stage (the cancer had spread to nearby lymph nodes, tissues, or organs), and 6% were found at a distant stage (the cancer had spread to distant parts of the body).

5-year relative survival

Overall, 91% of female breast cancer patients had not died from their cancer 5 years later. However, survival varied by stage at diagnosis.

Survival is higher when breast cancer is found before it has spread to other parts of the body. Screening can find breast cancers earlier. Mammograms are the best way for females of average risk to find breast cancer early, when it is easier to treat and before the tumor is big enough to feel or cause symptoms.

5-year limited duration prevalence

Among females diagnosed with breast cancer from 2016 to 2020, 1,127,409 were still alive on January 1, 2021.

Impact of COVID-19‎

This report includes new cancer cases diagnosed in 2020 and 2021, the first and second years of the COVID-19 pandemic. The COVID-19 pandemic disrupted health services, leading to delays and reductions in cancer screening and diagnosis, which may have contributed to lower incidence for most cancer sites in 2020. The numbers of new cases diagnosed in 2021 were a little lower than expected for some cancer types but returned to pre-pandemic counts for other cancer types. For more information, see the impact of COVID-19 on cancer incidence trends.


For more cancer data, visit U.S. Cancer Statistics. Use the Data Visualizations tool to make your own tables, graphs, and maps.

Data sources

Data are from U.S. Cancer Statistics, the official federal cancer statistics.

U.S. Cancer Statistics incidence data are from population-based registries that participate in CDC's National Program of Cancer Registries (NPCR), the National Cancer Institute's Surveillance, Epidemiology, and End Results Program, or both programs and met high-quality data criteria for data submitted in 2023, covering 98% of the U.S. population.

U.S. Cancer Statistics death data are from CDC's National Center for Health Statistics National Vital Statistics System and cover 100% of the U.S. population.

U.S. Cancer Statistics survival and prevalence data are from 43 NPCR registries that met high-quality data criteria for the 2023 data submission and conducted linkage with the National Death Index and/or active patient follow-up, covering 92% of the U.S. population. Five-year relative survival estimates are based on cases diagnosed from 2014 to 2020. Five-year limited-duration prevalence estimates are based on cases diagnosed from 2016 to 2020.

Suggested citation

Centers for Disease Control and Prevention. U.S. Cancer Statistics Female Breast Cancer Stat Bite. U.S. Department of Health and Human Services; 2024.